Safety of coagulation factor concentrates

This publication has 4 references indexed in Scilit:

• Successful Clinical Use of a Plasma-derived, Dual Virus Inactivated Factor VIII Concentrate Incorporating Solvent-detergent and Dry Heat Treatment
  Thrombosis and Haemostasis, 1997
• A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group
  Blood, 1993
• The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate [see comments]
  Blood, 1991
• Epidemiological investigation of the prevalence of von Willebrand's disease
  Blood, 1987